Lipoprotein(a) as a novel biomarker for predicting adverse outcomes in ischemic heart failure
Elevated Lp(a) levels were independently associated with an increased risk of MACE, mortality, and revascularization in IHF patients, with a stronger effect in obese individuals.
Authors
- Tienan Sun (ORCID: https://orcid.org/0000-0002-1718-2571)
- Meishi Ma
- Biyang Zhang (ORCID: https://orcid.org/0000-0002-2053-6692)
- Yinxiao Xu
- Zheng Chen (ORCID: https://orcid.org/0000-0001-7945-1186)
- Xin Huang (ORCID: https://orcid.org/0000-0001-8820-3213)
- Yujie Zhou (ORCID: https://orcid.org/0000-0002-9545-1984)
Institutions
- Capital Medical University (CN)
- Beijing Anzhen Hospital (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2024-09-05
- DOI
- https://doi.org/10.3389/fcvm.2024.1466146
- Citations
- 9
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 5.15
Funders
- National Key Research and Development Program of China